Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
Approximately 1 in 5 women who undergo CS will experience severe acute postoperative pain.
The severity of pain in the acute postoperative period is a significant predictor for the
development of chronic pain, which occurs in 9.2%-18% of women who undergo CS. Furthermore,
severe acute post-cesarean pain triples a woman's risk of developing postpartum depression
and negatively affects breastfeeding and infant care. For these reasons, it is imperative to
provide adequate postoperative analgesia in this patient population